MWM
HURA

Maltin Wealth Management’s TuHURA Biosciences HURA Stock Holding History

Maltin Wealth Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6
Closed -$1K – 114
2022
Q3 		$1K Hold
6
– – ﹤0.01% 105
2022
Q2 		$3K Hold
6
– – ﹤0.01% 111
2022
Q1 		$4K Hold
6
– – ﹤0.01% 112
2021
Q4 		$5K Hold
6
– – ﹤0.01% 114
2021
Q3 		$9K Buy
+6
New +$15.8K 0.01% 107

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Maltin Wealth Management's HURA Position: Q4 2022 in Review

Maltin Wealth Management sold out of TuHURA Biosciences (HURA) in Q4 2022, closing a stake of 6 shares — an estimated $1K sold.

Maltin Wealth Management first reported a position in HURA in Q3 2021 and held it in 5 quarters. The position peaked at $9K in Q3 2021. 10 funds tracked by Wall St. Rank hold HURA as of Q4 2022.

  • Maltin Wealth Management reported no remaining TuHURA Biosciences position as of Q4 2022 after selling out during the quarter.
  • Maltin Wealth Management sold 6 TuHURA Biosciences shares in Q4 2022, an estimated $1K.
  • Maltin Wealth Management first reported a position in TuHURA Biosciences in Q3 2021 and held it in 5 quarters.
  • Maltin Wealth Management's TuHURA Biosciences position peaked at $9K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2022.

Based on Maltin Wealth Management's 13F filing for Q4 2022, filed 17 Feb 2023.